
Basic Protective Measures Against COVID-19
COVID-19 is a new strain of the common cold that has been p...
COVID-19 is a new strain of the common cold that has been p...
Where is Ivosidenib used?
Ivosidenib is a medicine used in people with acute myeloid leukemia (AML). This is also used to treat AML that has not improved or has come back after prior treatment. This medication is used only in patients who have an isocitrate dehydrogenase-1 (IDH1) mutation in their AML. This is an FDA-approved prescription for oral use.
How does Ivosidenib work?
Ivosidenib is a type of targeted therapy called an isocitrate dehydrogenase-1 (IDH1) inhibitor. This works by directing and hindering IDH 1 enzyme. In several cancers, this receptor is intense that causes cells to develop and split too fast. By preventing these, Ivosidenib can slow or stop the growth of the tumor. Your doctor will test your tumor for this abnormality, which needs to be present to receive the medication.
How is Ivosidenib taken?
What are the possible side effects of Ivosidenib?
What are the precautions in taking Ivosidenib?